Under this "old" model of intellectual property (IP), biotech firms raced to file a "fortress" of patents around newly discovered genes, closing off avenues of research for their competitors.
Moreover, if doing away with closing loopholes goes for big businesses and small, then the small business owners who file a very different tax form than corporations do will want to see their overall tax burden lowered.